Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Keith Stewart

Showing results (1-10 of 215) with videos related to

Pageof 22
Sort By:
Future Oncology (London, England)|July 1, 2015
Carfilzomib for the treatment of patients with relapsed and/or refractory multiple myelomaA Keith Stewart
Hematology. American Society of Hematology. Education Program|December 17, 2009
Novel therapies for relapsed myelomaA Keith Stewart
Blood|April 4, 2009
Reduced-intensity allogeneic transplantation for myeloma: reality bitesA Keith Stewart
Science (New York, N.Y.)|January 18, 2014
Medicine. How thalidomide works against cancerA Keith Stewart
Blood|August 7, 2010
Union of forces advances myeloma careA Keith Stewart
Hematology (Amsterdam, Netherlands)|April 18, 2012
Novel therapeutics in multiple myelomaA Keith Stewart
Molecular Cancer Therapeutics|March 17, 2007
Targeted therapeutics for multiple myeloma: the arrival of a risk-stratified approachRafael Fonseca, A Keith Stewart
Expert Review of Molecular Diagnostics|July 11, 2007
Review of molecular diagnostics in multiple myelomaA Keith Stewart, Rafael Fonseca
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Prognostic and therapeutic significance of myeloma genetics and gene expression profilingA Keith Stewart, Rafael Fonseca
The New England Journal of Medicine|April 30, 2015
Treatment of relapsed multiple myelomaA Keith Stewart, Antonio Palumbo
Pageof 22

Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
Future Oncology (London, England)|July 1, 2015
Carfilzomib for the treatment of patients with relapsed and/or refractory multiple myelomaA Keith Stewart
Hematology. American Society of Hematology. Education Program|December 17, 2009
Novel therapies for relapsed myelomaA Keith Stewart
Blood|April 4, 2009
Reduced-intensity allogeneic transplantation for myeloma: reality bitesA Keith Stewart
Science (New York, N.Y.)|January 18, 2014
Medicine. How thalidomide works against cancerA Keith Stewart
Blood|August 7, 2010
Union of forces advances myeloma careA Keith Stewart
Hematology (Amsterdam, Netherlands)|April 18, 2012
Novel therapeutics in multiple myelomaA Keith Stewart
Molecular Cancer Therapeutics|March 17, 2007
Targeted therapeutics for multiple myeloma: the arrival of a risk-stratified approachRafael Fonseca, A Keith Stewart
Expert Review of Molecular Diagnostics|July 11, 2007
Review of molecular diagnostics in multiple myelomaA Keith Stewart, Rafael Fonseca
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Prognostic and therapeutic significance of myeloma genetics and gene expression profilingA Keith Stewart, Rafael Fonseca
The New England Journal of Medicine|April 30, 2015
Treatment of relapsed multiple myelomaA Keith Stewart, Antonio Palumbo
Pageof 22